Showing results (71-80 of 118) with videos related to

Sort By:
Pageof 12
Frontiers in Physiology|March 3, 2020
Echocardiographic Epicardial Adipose Tissue Thickness for Risk Stratification of Patients With Heart FailureValentina Parisi, Maddalena Conte, Laura Petraglia, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|August 3, 2020
Second European Society of Cardiology Cardiac Resynchronization Therapy Survey: the Italian cohortGiovanni L Botto, Maurizio Gasparini, Francesco M A Brasca, et al.
International Journal of Cardiology|January 12, 2017
Effectiveness of subcutaneous implantable cardioverter-defibrillator testing in patients with hypertrophic cardiomyopathyNiccoló Maurizi, Ilaria Tanini, Iacopo Olivotto, et al.
Pacing and Clinical Electrophysiology : PACE|April 28, 2021
Home delivery of the communicator for remote monitoring of cardiac implantable devices: A multicenter experience during the covid-19 lockdownMichele Magnocavallo, Alessia Bernardini, Marco Valerio Mariani, et al.
Heart Rhythm|April 18, 2018
Adherence to 2016 European Society of Cardiology guidelines predicts outcome in a large real-world population of heart failure patients requiring cardiac resynchronization therapyGiuseppe Stabile, Patrizia Pepi, Pietro Palmisano, et al.
European Journal of Heart Failure|January 10, 2018
Transcoronary concentration gradients of circulating microRNAs in heart failureSalvatore De Rosa, Francesca Eposito, Cristina Carella, et al.
Circulation. Heart Failure|September 14, 2013
Vascular endothelial growth factor blockade prevents the beneficial effects of β-blocker therapy on cardiac function, angiogenesis, and remodeling in heart failureGiuseppe Rengo, Alessandro Cannavo, Daniela Liccardo, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|September 19, 2023
Clinical course of hypertrophic cardiomyopathy patients implanted with a transvenous or subcutaneous defibrillatorPietro Francia, Matteo Ziacchi, Carmen Adduci, et al.
Journal of Cardiovascular Development and Disease|February 26, 2026
High-Risk Coronary Plaques and Carotid Duplex Findings in Asymptomatic Patients Undergoing Primary Prevention AssessmentLucio Addeo, Pasquale Guarini, Carlo Tedeschi, et al.
Circulation|August 24, 2013
β1-adrenergic receptor and sphingosine-1-phosphate receptor 1 (S1PR1) reciprocal downregulation influences cardiac hypertrophic response and progression to heart failure: protective role of S1PR1 cardiac gene therapyAlessandro Cannavo, Giuseppe Rengo, Daniela Liccardo, et al.
Pageof 12